Gesundheitsökonomische Aspekte der Kaltplasmatherapie:
                    exemplarische Betrachtung der Versorgung chronischer Wunden mithilfe des
                    Plasmajet kINPen MED

Witte, J.; Gensorowsky, Daniel; Zeitler, A.; Greiner, Wolfgang; Strohal, Robert

doi:10.1055/a-2001-1879

Cited by 1 publication

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…18 According to a recent calculation, the ACP approach is able to reduce treatment costs of patients with wound infections by about 50%. 12 Our data indicate that ACP also has preventive effects, which can last several months. Nevertheless, there seem to be no prophylactic long-term effects because 1 year freedom from DLI did not differ significantly between study groups.…”

Section: Discussionmentioning

confidence: 58%

See 1 more Smart Citation

Argon Cold Plasma Use and Driveline Infection in Left Ventricular Assist Device Implant Recipients

Lauenroth,

Zittermann,

Lucke

et al. 2023

ASAIO Journal

View full text Add to dashboard Cite

We conducted a prospective open-labeled, clinical trial, with a two-by-two factorial design, of argon cold plasma (ACP) application and two different types of driveline positioning for the prevention of driveline infection (DLI) in patients with a left ventricular assist device (LVAD) implant. Here, we present the results of ACP application versus no ACP application. Eighty patients were allocated to the control group (no preventive ACP use; n = 40) or ACP group (preventive ACP use for 30 days post-LVAD implantation; n = 40). Patients were followed up for 1 year. The secondary endpoint was survival on device. Preventive ACP use improved 30 day freedom from DLI significantly (100% vs. 85%; p = 0.012); results remained significant at 6 months (92% vs. 69%, p = 0.007) and were 55% and 60%, respectively (p = 0.65) at 1 year follow-up. With respect to survival on device, results in the control and ACP groups did not differ significantly at 30 days (97.5% vs. 100%, respectively; p = 0.32), but tended to be lower in the control group than in the ACP group at 1 year follow-up (74% vs. 90%, respectively; p = 0.09). In conclusion, preventive ACP use was able to significantly reduce DLI both during the application period and up to 6 months after LVAD implantation.

show abstract

Section: Discussionmentioning

confidence: 58%

“…Total costs (material plus time) of € 24 € (US$ 26) per patient and session have been calculated. 12 The control group (n = 40) received no additional anti-infective measure.…”

Section: Treatment Allocation and Driveline Infection Preventionmentioning

confidence: 99%

Argon Cold Plasma Use and Driveline Infection in Left Ventricular Assist Device Implant Recipients

Lauenroth,

Zittermann,

Lucke

et al. 2023

ASAIO Journal

View full text Add to dashboard Cite

show abstract

Gesundheitsökonomische Aspekte der Kaltplasmatherapie: exemplarische Betrachtung der Versorgung chronischer Wunden mithilfe des Plasmajet kINPen MED

Abstract: HinweisDieser Artikel wurde gemäß des Erratums vom 13.3.2023 geändert. ErratumIm oben genannten Artikel wurden die Trademark-Zeichen aus dem gesamten Artikel entfernt und die Jahreszahl des Copyrights wurde korrigiert, richtig ist 2023.

Cited by 1 publication

References 29 publications

Argon Cold Plasma Use and Driveline Infection in Left Ventricular Assist Device Implant Recipients

Argon Cold Plasma Use and Driveline Infection in Left Ventricular Assist Device Implant Recipients

Contact Info

Product

Resources

About